REGINA POOLE: Open Payments
NPI 1427250117 · BROOMALL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 28 payments from 16 companies in 2025. Trend: 2023 $954 · 2024 $629 · 2025 $742
Food & beverage: $642Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $121 |
| GlaxoSmithKline, LLC. | 4 | $90 |
| Merck Sharp & Dohme LLC | 3 | $89 |
| ABBVIE INC. | 3 | $67 |
| Gilead Sciences, Inc. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Tempus AI, Inc | 1 | $34 |
| Astellas Pharma US Inc | 2 | $33 |
| Genentech USA, Inc. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
Products named: ERLEADA, KEYTRUDA, IMBRUVICA, Trodelvy, ELIQUIS, JEMPERLI, XT CDX, Polivy.
Industry payments across PA — which companies pay providers there.
